DuPont Faces First Trial Involving West Virginia Chemical Leak

Bartlett, a 59 year-old resident of Guysville in Athens County, Ohio was diagnosed with kidney cancer in 1997. Among other charges, Bartlett accuses DuPont management of negligence for allowing the leak, fraud and concealment for failing to inform the public of the dangers, and trespass and battery for letting the pollutants enter her bloodstream. DuPont attorneys blame Barlett’s kidney cancer on other factors instead, including obesity.


DOJ, Appellate Court Debate “Lenient” Iran-Trading Settlement

Fokker had admitted to have violated the International Emergency Economic Powers Act between 2005 and 2010 by trading aircraft parts and other components to Iran, Burma (now Myanmar), and the Sudan, in violation of U.S. sanctions. The division, Fokker Services, voluntarily admitted the violations during the Department of Justice’s (DOJ) four-year probe in the matter, agreeing to forfeit $10.5 million in proceeds and pay a $10.5 million penalty as part of an 18-month deferred prosecution agreement.


Obama Scraps Federal College Ranking System for “Scorecard”

Unlike most college rating platforms, the scorecard contains a plethora of useful data that is usually unavailable from the private sector. Although prefacing by saying the data is based on students who have received federal grants and loans, the site contains income information, not just for recent grads, but also containing 10-year median income for graduates and loan default rates. The search-engine styled site also contains net costs for students from high-income and low-income families, as well as the ethnic diversity of particular colleges.


2nd Circuit Reinstates EEOC Gender Bias Suit vs. Parent Company of Jared, Kay Jewelers

The lawsuit’s reinstatement follows the April Supreme Court decision regarding Mach Mining v. EEOC, in which the Court ruled that judges could only review the details of the EEOC’s claims “on a limited basis.” The 2nd Circuit elaborated on April’s ruling, with Judge John Walker writing in the panel’s opinion that “Under Title VII, courts may review whether the EEOC conducted an investigation, but not the sufficiency of an investigation.” Judge Walker also explained the court’s rationale for such limitations, writing “Extensive judicial review of this sort would expend scarce resources and would delay and divert EEOC enforcement actions from … eliminating discrimination in the workplace.”


California Legislators Agree on Medical Marijuana Regulatory Framework

The bill also comes as residents will likely vote on legalizing marijuana for recreational use next year. As the current medical marijuana industry is regulated through a patchwork of city and local ordinances, Brown and other legislators have been trying to mitigate the concerns of industry lobbyists, law enforcement, local administrators, and opposition lawmakers in advance of the likely 2016 ballot measure.


Federal Regulators Abandon Cancer Study of Nuclear Plants

NAS began the study in 2010, and completed the first phase in 2012. The next phase had been underway for about three years when it was halted. The study was to have been an update to a 1990 review conducted by the National Cancer Institute, which analyzed cancer death rates in areas near 52 nuclear plants. That study concluded that there was no increased risk of cancer for people living close to the nuclear facilities.



XPO Logistics to Buy Con-Way for $3 Billion

Although the acquisition had been expected to easily pass a Federal Trade Commission (FTC) antitrust regulatory review, Morningstar has reported that New York-based firm Faruqi & Faruqi is investigating Con-Way’s board over alleged violation of fiduciary duties for selling the company at the $47.60 share price, that number is down from the stock’s 52-week high of $59.00. It remains to be seen if the inquiry will halt the deal’s approval. XPO expects the purchase to be completed by October.


FDA Issues Dosing Warning for Collegium’s Experimental Painkiller

Unlike most opioid painkillers, which are either taken on an empty stomach or without regard for food intake, users must take Xtampza after eating to release the maximum effects. The FDA warned that if Xtampza is taken without food, it will lead to inadequate pain control, and contribute to abuse and overdose by users who are seeking to remedy their pain.